Elara Pharmaceuticals Frequently Asked Questions (FAQ)
What is Elara Pharmaceuticals's latest funding round?
Elara Pharmaceuticals's latest funding round is Grant.
How much did Elara Pharmaceuticals raise?
Elara Pharmaceuticals raised a total of $6.4M.
Who are the investors of Elara Pharmaceuticals?
Investors of Elara Pharmaceuticals include BMBF GOBio, BioRN - Biotechnologie Rhein-Neckar, Wagnisfinanzierungsgesellschaft fuer Technologiefoerderung in Rheinland-Pfalz, KfW and EMBL Ventures.
Who are Elara Pharmaceuticals's competitors?
Competitors of Elara Pharmaceuticals include Kythera Biopharmaceuticals, Idenix Pharmaceuticals, ugichem, Callisto Pharmaceuticals, Excaliard Pharmaceuticals and 7 more.
Compare Elara Pharmaceuticals to Competitors
Inflazyme Pharmaceuticals is a biopharmaceutical company engaged in the discovery, development and commercialization of therapies for the treatment of respiratory and inflammatory diseases. The company's core focus is medicinal chemistry based, orally active, small molecules aimed at treating unmet medical needs.
Longevica is a biotechnology that is researching mechanisms of healthy aging and life extension. The company is also developing an open research tool for scientists and research institutions to access a data set that tracks the effects of pharmacological compounds for testing drugs.
Affibody is a private clinical-stage biotech company. It specializes in the discovery of antibody mimetics that provide biodistribution flexibility, tissue penetration, and tumor targeting. The company was founded in 1998 and is based in Solna, Sweden.
Sound Pharmaceuticals (SPI) is a biopharmaceutical company that develops prescription drugs that will enable doctors and patients to prevent and treat hearing loss, a disease that affects over 30 to 40 million Americans. It was founded in 2002 and is based in Seattle, Washington.
BIKAM Pharmaceuticals is a biopharmaceutical company. It focuses on the discovery and development of small-molecule therapeutics for the treatment of ophthalmic diseases and disorders, including retinitis pigmentosa. BIKAM Pharmaceuticals was founded in 2007 and is based in Cambridge, Massachusetts.
greenovation Biotech GmbH is engaged in the production of pharmaceutically highly-efficient glycoproteins